Skip to main content
Premium Trial:

Request an Annual Quote

Genaissance Shares Climb 7.6 Percent On News of Animal-genotyping Alliance

NEW YORK, Dec. 3 (GenomeWeb News) - Shares in Genaissance Pharmaceuticals were up 7.64 percent at $1.69 in mid-afternoon trading one day after the company announced an animal-genotyping collaboration with a British company.

Yesterday, Genaissance said it will use its HAP technology platform perform genotyping studies on three undisclosed meat animal species provided by Sygen International.

UK-based Sygen is an animal-breeding concern, which has two subsidiaries. One provides breeding stock to the North American pork industry, and the other supplies shrimp for cultivation.

Terms of the agreement were not disclosed.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.